| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/10/266:30 AM | $0.93 | $1.71 | +83.9% | +4,375% | $208.6M | $225.0M | +7.8% | +314% | |
| Q2 '26 | 8/12/266:30 AM | $0.81 | $0.74GAAP | -8.6% | +251% | $167.8M | $171.7M | +2.3% | ⚠ Check | |
| Q1 '26 | 5/11/266:30 AM | $0.39 | $0.52GAAP | +33.3% | +216% | $117.3M | $132.9M | +13.3% | ⚠ Check | |
| Q4 '25 | 3/5/266:30 AM | $0.33 | $0.15GAAP | -54.5% | +133% | $79.3M | $92.0M | +16.1% | ⚠ Check | |
| Q3 '25 | 11/3/256:30 AM | -$0.38 | -$0.04GAAP | +89.5% | +90% | $17.6M | $54.3M | ⚠ Check | ⚠ Check | |
| Q2 '25 | 8/12/256:30 AM | -$0.41 | -$0.49GAAP | -19.5% | -32% | $3.9M | $8.8M | +126% | +142% | |
| Q1 '25 | 5/8/256:30 AM | -$0.42 | -$0.45GAAP | -7.1% | +17% | $3.2M | $3.1M | -3.4% | +5% |
⚠ Potential error in calculation, check manually. The two revenue figures may be in different units or currencies.
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.